Antibe Therapeutics Inc.

(ATE:CA)

By |

Profile

Antibe Therapeutics Inc is a healthcare company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen. The company has two primary business segments: Antibe Therapeutics, a pharmaceutical development company, and Citagenix, a marketer and distributor of regenerative medicines serving the dental and orthopedic marketplaces.

Contact Information

Website: www.antibethera.com
Main Phone: +1 905 570-5103
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: CDX
CEO: Daniel Legault
Employees: 37
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.25 $ 0.005 (2.04%)
Last Price 0.25 Change $ 0.005 Change % 2.04 Tick N/A
Bid 0.24 Bid Size 85,000.00 Ask 0.25 Ask Size 10,500.00
Open 0.25 High 0.25 Low 0.25 Prev Close 0.25
Last Trade Volume 82,884 52 Wk Hi 0.79 52 Wk Low 0.13
Market Cap 53.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 214,905,232.00 EPS (TTM) -0.05 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.8 1.8 1.8 1.8
Low Target Price Estimate 1.8 1.8 1.8 1.8
Mean Target Price Estimate 1.8 1.8 1.8 1.8
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/06/18 04/06/18 04/06/18 04/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1